The long-term efficacy of combination antiretroviral drug therapy (HAART) for control of human immunodeficiency virus 1 (HIV-1) infection appears to require augmentation of anti-HIV-1 CD8 ? T cell responses using immunotherapeutic strategies. In the current phase of this R01 grant, we have shown that CD40L-matured dendritic cells (DCs) loaded with HIV-I proteins, peptides or HIV-1 infected apoptotic cells, serve as potent immunogens for activation of memory and primary anti- HIV-1 CD8 ? and CD4 + T cells. We hypothesize that the inherent nafve repertoire of CD8 ? T cells present prior to HIV-1 infection is sufficiently broad to recognize infecting viruses, as well as the variants of the CTL epitopes that evolve over the course of infection. Therefore, in Aim 1 we propose to test primary CD8 ? T cell reactivity in samples obtained prior to infection for recognition of infecting, autologous viruses as well as variants of the epitopes recognized during early infection using autologous HIV-1 infected apoptotic bodies.
In Aim 2, we will characterize sequences of the infecting viruses and the later- evolving variants of epitopes recognized during early infection.
In Aim 3, we will assess the antigen processing mechanisms using DC live cell imaging and expression of markers involved in antigen processing pathways. Since the reconstitution of anti-HIV-1 responses following HAART has a number of similarities to the development of anti-HIV-1 responses following infection, characterization of pre-infection nafve T cell responses will help formulate model strategies to enhance immune responses following HAART. We propose that this DC-apoptotic cell model may be antigenic forms of HIV-1 and can be a vehicle for therapeutic

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Method to Extend Research in Time (MERIT) Award (R37)
Project #
Application #
Study Section
Special Emphasis Panel (NSS)
Program Officer
Bridges, Sandra H
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pittsburgh
Internal Medicine/Medicine
Schools of Public Health
United States
Zip Code
Macatangay, Bernard J C; Riddler, Sharon A; Wheeler, Nicole D et al. (2016) Therapeutic Vaccination With Dendritic Cells Loaded With Autologous HIV Type 1-Infected Apoptotic Cells. J Infect Dis 213:1400-9
Zaccard, C R; Rinaldo, C R; Mailliard, R B (2016) Linked in: immunologic membrane nanotube networks. J Leukoc Biol 100:81-94
Macatangay, Bernard J C; Rinaldo, Charles R (2015) Preserving HIV-specific T cell responses: does timing of antiretroviral therapy help? Curr Opin HIV AIDS 10:55-60
Zaccard, Colleen R; Watkins, Simon C; Kalinski, Pawel et al. (2015) CD40L induces functional tunneling nanotube networks exclusively in dendritic cells programmed by mediators of type 1 immunity. J Immunol 194:1047-56
McKinnon, John E; Mailliard, Robbie B; Swindells, Susan et al. (2014) Baseline natural killer and T cell populations correlation with virologic outcome after regimen simplification to atazanavir/ritonavir alone (ACTG 5201). PLoS One 9:e95524
Smith, Kellie N; Mailliard, Robbie B; Larsen, Brendan B et al. (2014) Dendritic cells restore CD8+ T cell reactivity to autologous HIV-1. J Virol 88:9976-90
Zaccard, Colleen R; Watkins, Simon C; Ayyavoo, Velpandi et al. (2014) HIV's ticket to ride: Cytotoxic T-lymphocyte-activated dendritic cells exploited for virus intercellular transfer. AIDS Res Hum Retroviruses 30:1023-4
Melhem, Nada M; Smith, Kellie N; Huang, Xiao-Li et al. (2014) The impact of viral evolution and frequency of variant epitopes on primary and memory human immunodeficiency virus type 1-specific CD8⁺ T cell responses. Virology 450-451:34-48
Rappocciolo, Giovanna; Jais, Mariel; Piazza, Paolo et al. (2014) Alterations in cholesterol metabolism restrict HIV-1 trans infection in nonprogressors. MBio 5:e01031-13
Rinaldo, Charles R (2013) HIV-1 Trans Infection of CD4(+) T Cells by Professional Antigen Presenting Cells. Scientifica (Cairo) 2013:164203

Showing the most recent 10 out of 32 publications